Form 4: Inovio Pharmaceuticals Director Simon X. Benito Reports Stock Transaction
SEC Form 4 Filing
Director Simon X. Benito reports a transaction involving Inovio Pharmaceuticals common stock and restricted stock units.
Summary
- On May 21, 2025, Simon X. Benito, a director of Inovio Pharmaceuticals, reported a transaction.
- The transaction involved the vesting of 2,167 restricted stock units, each representing a contingent right to receive one share of common stock.
- Following the transaction, Benito directly owns 12,191 shares of Inovio Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of transaction and vesting of restricted stock units. |
Keywords
Form 4, Inovio Pharmaceuticals, Director, Stock Transaction, Restricted Stock Units, Common Stock, Beneficial Ownership, INO, Simon X. Benito
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.